Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AddLife AB (publ) stock logo
ADDLF
AddLife AB (publ)
C$7.94
C$7.94
C$7.94
C$7.94
N/AN/A3,550 shsN/A
Ansell Limited stock logo
ANSLF
Ansell
$18.00
$18.00
$15.05
$23.42
N/AN/A700 shsN/A
Ansell Limited stock logo
ANSLY
Ansell
$79.49
$79.80
$53.43
$94.74
N/AN/A171 shs1 shs
Sartorius Stedim Biotech S.A. stock logo
SDMHF
Sartorius Stedim Biotech
$244.35
$229.76
$158.00
$245.20
N/AN/A2,255 shsN/A
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AddLife AB (publ) stock logo
ADDLF
AddLife AB (publ)
0.00%0.00%0.00%0.00%0.00%
Ansell Limited stock logo
ANSLF
Ansell
0.00%0.00%0.00%0.00%+3.45%
Ansell Limited stock logo
ANSLY
Ansell
0.00%0.00%-0.64%+6.06%+13.54%
Sartorius Stedim Biotech S.A. stock logo
SDMHF
Sartorius Stedim Biotech
0.00%-0.35%+4.05%+12.09%+38.68%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AddLife AB (publ) stock logo
ADDLF
AddLife AB (publ)
N/AN/AN/AN/AN/AN/AN/AN/A
Ansell Limited stock logo
ANSLF
Ansell
N/AN/AN/AN/AN/AN/AN/AN/A
Ansell Limited stock logo
ANSLY
Ansell
N/AN/AN/AN/AN/AN/AN/AN/A
Sartorius Stedim Biotech S.A. stock logo
SDMHF
Sartorius Stedim Biotech
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AddLife AB (publ) stock logo
ADDLF
AddLife AB (publ)
0.00
N/AN/AN/A
Ansell Limited stock logo
ANSLF
Ansell
0.00
N/AN/AN/A
Ansell Limited stock logo
ANSLY
Ansell
0.00
N/AN/AN/A
Sartorius Stedim Biotech S.A. stock logo
SDMHF
Sartorius Stedim Biotech
2.00
HoldN/AN/A

Current Analyst Ratings Breakdown

Latest SDMHF, ADDLF, ANSLY, and ANSLF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/21/2025
Sartorius Stedim Biotech S.A. stock logo
SDMHF
Sartorius Stedim Biotech
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Sector Perform
(Data available from 7/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AddLife AB (publ) stock logo
ADDLF
AddLife AB (publ)
N/AN/AN/AN/AN/AN/A
Ansell Limited stock logo
ANSLF
Ansell
N/AN/AN/AN/AN/AN/A
Ansell Limited stock logo
ANSLY
Ansell
N/AN/AN/AN/AN/AN/A
Sartorius Stedim Biotech S.A. stock logo
SDMHF
Sartorius Stedim Biotech
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AddLife AB (publ) stock logo
ADDLF
AddLife AB (publ)
N/AN/A0.00N/AN/AN/AN/AN/A
Ansell Limited stock logo
ANSLF
Ansell
N/A$0.3158.27N/AN/AN/AN/A8/26/2025 (Estimated)
Ansell Limited stock logo
ANSLY
Ansell
N/A$1.2464.33N/AN/AN/AN/A8/26/2025 (Estimated)
Sartorius Stedim Biotech S.A. stock logo
SDMHF
Sartorius Stedim Biotech
N/A$4.3156.69N/AN/AN/AN/A7/22/2025 (Estimated)
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AddLife AB (publ) stock logo
ADDLF
AddLife AB (publ)
N/AN/AN/AN/AN/A
Ansell Limited stock logo
ANSLF
Ansell
$0.402.24%N/A130.40%N/A
Ansell Limited stock logo
ANSLY
Ansell
$0.700.88%N/A56.91%N/A
Sartorius Stedim Biotech S.A. stock logo
SDMHF
Sartorius Stedim Biotech
$1.200.49%N/A27.84%N/A

Institutional Ownership

CompanyInstitutional Ownership
AddLife AB (publ) stock logo
ADDLF
AddLife AB (publ)
N/A
Ansell Limited stock logo
ANSLF
Ansell
38.97%
Ansell Limited stock logo
ANSLY
Ansell
0.60%
Sartorius Stedim Biotech S.A. stock logo
SDMHF
Sartorius Stedim Biotech
9.21%

Insider Ownership

CompanyInsider Ownership
AddLife AB (publ) stock logo
ADDLF
AddLife AB (publ)
N/A
Ansell Limited stock logo
ANSLF
Ansell
N/A
Ansell Limited stock logo
ANSLY
Ansell
N/A
Sartorius Stedim Biotech S.A. stock logo
SDMHF
Sartorius Stedim Biotech
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
AddLife AB (publ) stock logo
ADDLF
AddLife AB (publ)
2,289N/AN/ANot Optionable
Ansell Limited stock logo
ANSLF
Ansell
14,000N/AN/ANot Optionable
Ansell Limited stock logo
ANSLY
Ansell
14,000N/AN/ANot Optionable
Sartorius Stedim Biotech S.A. stock logo
SDMHF
Sartorius Stedim Biotech
10,382N/AN/ANot Optionable

Recent News About These Companies

Sartorius Stedim Biotech S.A. (SDMHF) - Yahoo Finance
Sartorius Stedim Biotech (0RG8) Receives a Buy from Jefferies
Goldman Sachs Keeps Their Buy Rating on Sartorius Stedim Biotech (0RG8)
Sartorius Stedim Biotech (0RG8) Gets a Buy from RBC Capital
UBS Remains a Hold on Sartorius Stedim Biotech (0RG8)
Goldman Sachs upgrades Sartorius Stedim Biotech (0RG8) to a Buy
RBC Capital Sticks to Their Buy Rating for Sartorius Stedim Biotech (0RG8)
AddLife AB (publ) stock logo

AddLife AB (publ) OTCMKTS:ADDLF

C$7.94 0.00 (0.00%)
As of 07/17/2025

AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for plastic consumables, cell biology, reagents, lab, and other instruments. The Medtech segment provides medical device products for surgery, thoracic medicine, neurology, wound care, anaesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare, as well as assistive technology for senior citizens and disabled children. It operates in Sweden, the United Kingdom, Ireland, Spain, Denmark, Norway, Italy, Finland, Switzerland, Germany, rest of Europe, and internationally. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden.

Ansell stock logo

Ansell OTCMKTS:ANSLF

$18.00 0.00 (0.00%)
As of 07/17/2025

Ansell Limited designs, develops, and manufactures protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates in two segments, Healthcare and Industrial. The Healthcare segment manufactures and markets solutions comprising surgical gloves, single use and examination gloves, and clean and sterile gloves and garments, as well as consumables used by hospitals, surgical centers, dental practices, veterinary clinics, first responders, manufacturers, auto repair shops, chemical plants, laboratories, and life sciences and pharmaceutical companies. The Industrial segment manufactures and markets hand and chemical protective clothing solutions for a range of industrial applications, including automotive, chemical, metal fabrication, machinery and equipment, food, construction, mining, oil and gas, utilities, logistics, and first responders. The company was formerly known as Pacific Dunlop Limited and changed its name to Ansell Limited in 2002. Ansell Limited was founded in 1893 and is based in Richmond, Australia.

Ansell stock logo

Ansell OTCMKTS:ANSLY

$79.49 0.00 (0.00%)
As of 07/17/2025

Ansell Limited designs, develops, and manufactures protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates in two segments, Healthcare and Industrial. The Healthcare segment manufactures and markets solutions comprising surgical gloves, single use and examination gloves, and clean and sterile gloves and garments, as well as consumables used by hospitals, surgical centers, dental practices, veterinary clinics, first responders, manufacturers, auto repair shops, chemical plants, laboratories, and life sciences and pharmaceutical companies. The Industrial segment manufactures and markets hand and chemical protective clothing solutions for a range of industrial applications, including automotive, chemical, metal fabrication, machinery and equipment, food, construction, mining, oil and gas, utilities, logistics, and first responders. The company was formerly known as Pacific Dunlop Limited and changed its name to Ansell Limited in 2002. Ansell Limited was founded in 1893 and is based in Richmond, Australia.

Sartorius Stedim Biotech stock logo

Sartorius Stedim Biotech OTCMKTS:SDMHF

$244.35 0.00 (0.00%)
As of 07/17/2025

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.